{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:58:55Z","timestamp":1786597135000,"version":"build-2736575974"},"reference-count":35,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["GV\/2018\/127"],"award-info":[{"award-number":["GV\/2018\/127"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["APOTIP\/2017\/012"],"award-info":[{"award-number":["APOTIP\/2017\/012"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["GV\/2014\/132"],"award-info":[{"award-number":["GV\/2014\/132"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["IFI18\/00015"],"award-info":[{"award-number":["IFI18\/00015"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01036"],"award-info":[{"award-number":["PI16\/01036"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00994"],"award-info":[{"award-number":["PI19\/00994"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["DTS17\/00132"],"award-info":[{"award-number":["DTS17\/00132"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019179","name":"Fundaci\u00f3n Bancaria Caixa d'Estalvis i Pensions de Barcelona","doi-asserted-by":"publisher","award":["ID 100010434"],"award-info":[{"award-number":["ID 100010434"]}],"id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Sepsis management remains one of the most important challenges in modern clinical practice. Rapid progression from sepsis to septic shock is practically unpredictable, hence the critical need for sepsis biomarkers that can help clinicians in the management of patients to reduce the probability of a fatal outcome. Circulating nucleoproteins released during the inflammatory response to infection, including neutrophil extracellular traps, nucleosomes, and histones, and nuclear proteins like HMGB1, have been proposed as markers of disease progression since they are related to inflammation, oxidative stress, endothelial damage, and impairment of the coagulation response, among other pathological features. The aim of this work was to evaluate the actual potential for decision making\/outcome prediction of the most commonly proposed chromatin-related biomarkers (i.e., nucleosomes, citrullinated H3, and HMGB1). To do this, we compared different ELISA measuring methods for quantifying plasma nucleoproteins in a cohort of critically ill patients diagnosed with sepsis or septic shock compared to nonseptic patients admitted to the intensive care unit (ICU), as well as to healthy subjects. Our results show that all studied biomarkers can be used to monitor sepsis progression, although they vary in their effectiveness to separate sepsis and septic shock patients. Our data suggest that HMGB1\/citrullinated H3 determination in plasma is potentially the most promising clinical tool for the monitoring and stratification of septic patients.<\/jats:p>","DOI":"10.3390\/ijms22189935","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T21:47:21Z","timestamp":1631656041000},"page":"9935","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparative Analysis of Chromatin-Delivered Biomarkers in the Monitoring of Sepsis and Septic Shock: A Pilot Study"],"prefix":"10.3390","volume":"22","author":[{"given":"Jes\u00fas","family":"Beltr\u00e1n-Garc\u00eda","sequence":"first","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain"},{"name":"INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"},{"name":"Biomedical Research Networking Center of Rare Diseases (CIBERER), Institute of Health Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Mancl\u00fas","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n e Innovaci\u00f3n en Bioingenier\u00eda, Universitat Polit\u00e8cnica de Val\u00e8ncia, 46022 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Garc\u00eda-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain"},{"name":"Biomedical Research Networking Center of Rare Diseases (CIBERER), Institute of Health Carlos III, 28029 Madrid, Spain"},{"name":"EpiDisease SL (Spin-Off Ciber-ISCIII), 46980 Paterna, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9149-0310","authenticated-orcid":false,"given":"Nieves","family":"Carbonell","sequence":"additional","affiliation":[{"name":"INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"},{"name":"Intensive Care Unit, Clinical University Hospital of Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ferreres","sequence":"additional","affiliation":[{"name":"INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"},{"name":"Intensive Care Unit, Clinical University Hospital of Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Rodr\u00edguez-Gimillo","sequence":"additional","affiliation":[{"name":"INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"},{"name":"Intensive Care Unit, Clinical University Hospital of Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9903-511X","authenticated-orcid":false,"given":"Concepci\u00f3n","family":"Garc\u00e9s","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3715-1980","authenticated-orcid":false,"given":"Federico V.","family":"Pallard\u00f3","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain"},{"name":"INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"},{"name":"Biomedical Research Networking Center of Rare Diseases (CIBERER), Institute of Health Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7547-7872","authenticated-orcid":false,"given":"Jos\u00e9 L.","family":"Garc\u00eda-Gim\u00e9nez","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain"},{"name":"INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"},{"name":"Biomedical Research Networking Center of Rare Diseases (CIBERER), Institute of Health Carlos III, 28029 Madrid, Spain"},{"name":"EpiDisease SL (Spin-Off Ciber-ISCIII), 46980 Paterna, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6884-765X","authenticated-orcid":false,"given":"\u00c1ngel","family":"Montoya","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n e Innovaci\u00f3n en Bioingenier\u00eda, Universitat Polit\u00e8cnica de Val\u00e8ncia, 46022 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7981-7157","authenticated-orcid":false,"given":"Carlos","family":"Rom\u00e1-Mateo","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain"},{"name":"INCLIVA Biomedical Research Institute, 46010 Valencia, Spain"},{"name":"Biomedical Research Networking Center of Rare Diseases (CIBERER), Institute of Health Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Joffre, J., and Hellman, J. (2021). Oxidative stress and endothelial dysfunction in sepsis and acute inflammation. Antioxid. Redox Signal.","DOI":"10.1089\/ars.2021.0027"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.euroneuro.2016.10.006","article-title":"Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial","volume":"26","author":"Beraha","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19960","article-title":"Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: A systematic review and cost-effectiveness analysis","volume":"19","author":"Westwood","year":"2015","journal-title":"Health Technol. Assess."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: A randomised, controlled, open-label trial","volume":"16","author":"Beishuizen","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.peptides.2004.06.019","article-title":"Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients","volume":"25","author":"Struck","year":"2004","journal-title":"Peptides"},{"key":"ref_7","first-page":"w13542","article-title":"Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia","volume":"142","author":"Suberviola","year":"2012","journal-title":"Swiss Med. Wkly."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MCC.0b013e3282c9ac2a","article-title":"Biomarkers to improve diagnostic and prognostic accuracy in systemic infections","volume":"13","author":"Schuetz","year":"2007","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Silvestre, J., Coelho, L., and P\u00f3voa, P. (2010). Should C-reactive protein concentration at ICU discharge be used as a prognostic marker?. BMC Anesthesiol., 10.","DOI":"10.1186\/1471-2253-10-17"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc8872","article-title":"Sepsis biomarkers: A review","volume":"14","author":"Pierrakos","year":"2010","journal-title":"Crit. Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2812","DOI":"10.1038\/cddis.2017.52","article-title":"The role of extracellular histone in organ injury","volume":"8","author":"Silk","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jth.13223","article-title":"Extracellular histones reduce survival and angiogenic responses of late outgrowth progenitor and mature endothelial cells","volume":"14","author":"Mena","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/jcmm.13088","article-title":"Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells","volume":"21","author":"Hermenegildo","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/CCM.0000000000000879","article-title":"Septic shock sera containing circulating histones induce dendritic cell\u2013regulated necrosis in fatal septic shock patients","volume":"43","author":"Raffray","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.2053","article-title":"Extracellular histones are major mediators of death in sepsis","volume":"15","author":"Xu","year":"2009","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1016\/j.bbadis.2018.07.010","article-title":"Extracellular histones activate autophagy and apoptosis via mTOR signaling in human endothelial cells","volume":"1864","author":"Cabellos","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Garc\u00eda Gim\u00e9nez, J.L., Rom\u00e1 Mateo, C., Seco Cervera, M., Iba\u00f1ez Cabellos, J.S., and Pallard\u00f3, F.V. (2016). Chapter 25\u2014Circulating histones and nucleosomes as biomarkers in sepsis and septic shock A2\u2014Garc\u00eda-Gim\u00e9nez, Jos\u00e9 Luis. Epigenetic Biomarkers and Diagnostics, Academic Press.","DOI":"10.1016\/B978-0-12-801899-6.00025-5"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.thromres.2015.06.035","article-title":"Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients","volume":"136","author":"Wildhagen","year":"2015","journal-title":"Thromb. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.2119\/molmed.2015.00087","article-title":"High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule","volume":"21","author":"Yang","year":"2015","journal-title":"Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.immuni.2018.08.016","article-title":"The Endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis","volume":"49","author":"Deng","year":"2018","journal-title":"Immunity"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101890","DOI":"10.1016\/j.redox.2021.101890","article-title":"Endothelial specific deletion of HMGB1 increases blood pressure and retards ischemia recovery through eNOS and ROS pathway in mice","volume":"41","author":"Zhou","year":"2021","journal-title":"Redox Biol."},{"key":"ref_22","first-page":"1","article-title":"A new mass spectrometry-based method for the quantification of histones in plasma from septic shock patients","volume":"7","author":"Carbonell","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1097\/CCM.0b013e318265695f","article-title":"Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C","volume":"40","author":"Zeerleder","year":"2012","journal-title":"Crit. Care Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.surg.2014.04.009","article-title":"Citrullinated histone H3: A novel target for the treatment of sepsis","volume":"156","author":"Li","year":"2014","journal-title":"Surgery"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1097\/CCM.0000000000001162","article-title":"Circulating histones are major mediators of cardiac injury in patients with sepsis","volume":"43","author":"Alhamdi","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00109-014-1148-z","article-title":"Extracellular histones in tissue injury and inflammation","volume":"92","author":"Allam","year":"2014","journal-title":"J. Mol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1111\/jcmm.13797","article-title":"Biology, role and therapeutic potential of circulating histones in acute inflammatory disorders","volume":"22","author":"Szatmary","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/JLB.3MIR1218-497R","article-title":"Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation","volume":"106","author":"Deng","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: Analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1016\/j.ijid.2012.03.007","article-title":"Circulating nucleosomes as a predictor of sepsis and organ dysfunction in critically ill patients","volume":"16","author":"Chen","year":"2012","journal-title":"Int. J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2217\/epi-2019-0329","article-title":"Epigenetic biomarkers for human sepsis and septic shock: Insights from immunosuppression","volume":"12","author":"Carbonell","year":"2020","journal-title":"Epigenomics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clinbiochem.2016.11.005","article-title":"Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling","volume":"50","author":"Basso","year":"2016","journal-title":"Clin. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/01616412.2018.1497254","article-title":"Association of circulating blood HMGB1 levels with ischemic stroke: A systematic review and meta-analysis","volume":"40","author":"Le","year":"2018","journal-title":"Neurol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mvr.2017.02.005","article-title":"Blockade of HMGB1 preserves vascular homeostasis and improves blood perfusion in rats of acute limb ischemia\/reperfusion","volume":"112","author":"Liu","year":"2017","journal-title":"Microvasc. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00134-008-1032-9","article-title":"HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis","volume":"34","author":"Karlsson","year":"2008","journal-title":"Intensive Care Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/18\/9935\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:02:42Z","timestamp":1760166162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/18\/9935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":35,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["ijms22189935"],"URL":"https:\/\/doi.org\/10.3390\/ijms22189935","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]}}}